tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
Holding TLSI?
Track your performance easily

TriSalus Life Sciences (TLSI) Financial Statements

33 Followers

TriSalus Life Sciences Financial Overview

TriSalus Life Sciences's market cap is currently ―. The company's EPS TTM is $-2.499; its P/E ratio is ―; TriSalus Life Sciences is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 7.35M$ 7.36M$ 6.46M$ 13.32M$ 5.19M
Gross Profit$ 6.34M$ 6.45M$ 5.49M$ 11.30M$ 4.60M
EBIT$ -2.40M$ -3.45M$ -13.21M$ -35.51M$ -1.28M
EBITDA$ -1.76M$ -2.76M$ -12.95M$ -35.30M$ -1.28M
Net Income Common Stockholders$ -3.20M$ -5.13M$ -14.02M$ -60.09M$ -1.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.29M$ 16.48M$ 3.97M$ 11.78M$ 21.38M
Total Assets$ 27.48M$ 32.43M$ 17.89M$ 25.73M$ 33.55M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 47.91M$ 56.58M$ 52.81M$ 51.66M$ 25.07M
Stockholders Equity$ -20.43M$ -24.15M$ -34.92M$ -25.94M$ 8.49M
Cash Flow-
Free Cash Flow$ -11.02M$ -13.48M$ -10.93M$ -9.55M$ -40.60M
Operating Cash Flow$ -10.85M$ -13.42M$ -10.87M$ -8.85M$ -40.18M
Investing Cash Flow$ -169.00K$ -60.00K$ -66.00K$ -700.00K$ -9.54M
Financing Cash Flow$ 5.82M$ 25.99M$ 3.13M$ 43.00K$ 61.74M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

TriSalus Life Sciences Debt to Assets

TriSalus Life Sciences Cash Flow

TriSalus Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis